Eriko Tokunaga

基本信息

Career Trajectory

Bio

Principal Investigator
乳癌 / サブタイプ / 染色体不安定性 / ホルモン受容体 / 治療標的 / Akt / HER2 / 外科 / 腫瘍浸潤リンパ球 / 術前化学療法 / がん幹細胞 / 化学療法 / 癌抑制遺伝子 / ER陽性乳癌 / APOBEC3B / 遺伝子変異 / DNA修復 / GATA-3 / FOXA1 / ホルモン感受性 / ホルモン抵抗性 / ホルモン療法 / FANCF / triple negative乳癌 / 悪性度 / triple negative(TN)乳癌 / FANCJ / LOH / BRCA1 / triple negative (TN)乳癌 / cancer stem cell / FA経路 / BRCA / basal-like / トリプルネガティブ / ホルモン治療 / PR / PTEN / PI3K / neu / Her2 / トリコスタチンA / アポトーシス / MAPK / SAHA / TSA / HDAC阻害剤

Research Interests

Papers共 332 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Patient-reported Outcomes from DESTINY-Breast04: Trastuzumab Deruxtecan Versus Physician's Choice of Chemotherapy in Patients with HER2-low Mbc

Naoto T Ueno,Francesco Cottone, Kyle Dunton,William Jacot,Toshinari Yamashita,Joohyuk Sohn,Eriko Tokunaga,Aleix Prat,Junji Tsurutani,Yeon Hee Park,Hope S Rugo,Binghe Xu,Fatima Cardoso,Zahi Mitri,Reshma Mahtani, Cecilia Orbegoso Aguilar, Feng Xiao,Nadia Harbeck, David A Cameron,Shanu Modi

The oncologistno. 5 (2025)

Cited0Views0WOSBibtex

The Impact of Breast Surgery and Systemic Therapy on the Survival of Patients with De Novo Stage IV Breast Cancer

Eriko Tokunaga,Yumiko Koi,Wakako Tajiri,Chinami Koga,Hideki Ijichi,Sayuri Akiyoshi,Junji Kawasaki,Yoshiaki Nakamura,Kenichi Taguchi,Masahiro Okamoto

Breast Cancerpp.1-8, (2025)

Cited0Views0WOSBibtex

Trastuzumab Deruxtecan Versus Treatment of Physician’s Choice in Previously Treated Asian Patients with HER2-low Unresectable/metastatic Breast Cancer: Subgroup Analysis of the DESTINY-Breast04 Study

Toshinari Yamashita,Joo Hyuk Sohn,Eriko Tokunaga,Naoki Niikura,Yeon Hee Park,Keun Seok Lee,Yee Soo Chae,Binghe Xu,Xiaojia Wang,Seock-Ah Im,Wei Li,Yen-Shen Lu, Cecilia Orbegoso Aguilar,Soichiro Nishijima,Yuji Nishiyama,Masahiro Sugihara,Shanu Modi,Junji Tsurutani

Breast Cancerpp.1-11, (2024)

Cited0Views0WOSBibtex

Mutation Spectra of the BRCA1/2 Genes in Human Breast and Ovarian Cancer and Germline

Yumiko Koi,Arisa Watanabe, Akari Kawasaki, Satomi Ideo, Nao Matsutani,Kaname Miyashita,Seijiro Shioi,Eriko Tokunaga,Mototsugu Shimokawa,Yoshimichi Nakatsu,Isao Kuraoka,Shinya Oda

Environmental and Molecular Mutagenesisno. 5 (2024): 179-186

Cited0Views0WOSBibtex

Abstract PO3-11-11: Reproductive Concerns of Japanese Young Women with Breast Cancer: a Longitudinal Study

Chie Watanabe,Hiroko Bando,Akemi Kataoka,Mai Okazaki,Tadahiko Shien,Eriko Tokunaga,Takashi Kuwayama,Chikako Shimizu

Cancer Research（2024）

Cited0Views0Bibtex

Abstract PO1-05-05: Overall Survival (OS) and Subsequent Therapy Patterns in Japanese Patients with HR+/HER2− Advanced Breast Cancer (ABC) Treated with Palbociclib (PAL) Plus Letrozole (LET) in First-Line Setting (1L)

Masato Takahashi,Tomofumi Osako,Hiroyuki Yasojima,Kenichi Inoue,Masahiro Kawashima,Hideki Maeda,Mitsuya Ito,Yasuaki Sagara,Kan Yonemori,Masaya Hattori,Naohito Yamamoto,Eriko Tokunaga,Shozo Ohsumi,Yutaka Yamamoto,Akemi Ichikawa,Yasuaki Muramatsu,Norikazu Masuda

Cancer Researchno. 9_Supplement (2024): PO1-05

Cited0Views0Bibtex

The Clinical Impact of NOLUS in Unresectable/metastatic Hormone Receptor-Positive (Hr+)/her2-Negative Breast Cancer

Wakako Tajiri, Yoshiaki Nakamura,Junji Kawasaki,Yumiko Koi,Sayuri Akiyoshi,Chinami Koga,Eriko Tokunaga

CANCER RESEARCHno. 9 (2024)

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

部長

Papers共 332 篇Author StatisticsCo-AuthorSimilar Experts